Skip to main content
  • English
  • Français
  • Español
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Multiple sclerosis and microbiota: does meat consumption play a role?
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographic
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Multiple sclerosis and microbiota: does meat consumption play a role?
Gastroenterology

Multiple sclerosis and microbiota: does meat consumption play a role?

Neurodegenerative disease
Gastroenterology

Multiple sclerosis (MS) is an autoimmune neurodegenerative disease that affects 2.5 million people worldwide. A recent study published in eBioMedicine shows a network of associations between meat consumption, an increase in certain blood metabolites and pro-inflammatory markers, and fewer polysaccharide-digesting bacteria in patients with this disease. Explanations. 

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographic
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • Mail

About this article

Created 15 April 2022
Updated 21 April 2022

Recently, research has revealed the involvement of gut microbiota (GM) in the pathogenesis of MS, yet little is still known about its mechanisms.

A novel multiomic approach

For the first time, a research team has investigated interactions between diet, immune system, metabolism and gut microbiota in the development and progression of MS. For this, the researchers adopted a multiomic methodology.

This novel approach was the subject of a 6-month study. Blood and stools from the 49 participants (24 untreated MS patients and 25 non-diseased individuals) were collected at baseline and 6 months later. The metabolic profiles and GM of all participants remained stable for more than 6 months. Participants were also asked to record what they ate at each meal.

An altered relationship between gut microbiota and the immune system in MS patients

The results were similar to those of previous studies: on the whole, both groups share a similar bacterial community structure. However, MS patients had a lower abundance of bacteria with immunomodulatory properties. Moreover, the microbiota of patients differed depending on the extent of their disability, suggesting a possible link between certain species and disease severity. 

The results of the multiomic analyses also suggest dysfunctional homeostasis of microbiome–immune system interactions, because a disrupted immune cell–microbiome relationship and modification of the blood metabolic profile were observed in the group of MS patients.

Meat consumption: a possible explanation? 

Study of the participants’ food diaries played a key role in this research.

The researchers found that MS patients consumed more meat. This consumption was correlated with an increase in the quantity of Th17 cells, involved in the autoimmune process, and of S-adenosyl-L-methionine (SAM), a metabolite produced from methionine (an amino acid enriched in meat) and involved in the activation of Th17 cells. Conversely, MS patients had reduced proportions of B. thetaiotaomicron bacteria, known for being highly capable of digesting polysaccharides.

A new therapeutic approach? 

This data points to pathways of interaction between diet, gut microbiota, immune response and blood metabolome through B. thetaiotaomicron, Th17 and SAM. For the authors, these results suggest that decreasing dietary consumption of meat or methionine could reduce the number of circulating pro-inflammatory Th17 cells in MS patients.

This study, and its promising results, could pave the way for a better understanding of the regulatory pathways between diet, metabolites, immune response and microbiota, to prevent multiple sclerosis from worsening and possibly open up avenues for new therapeutic targets.  This study has been widely reported in the medical press and is of particular clinical interest. It will be discussed on World MS Day on May 30.

Sources

Cantoni C, Lin Q, Dorsett Y,et al.; Alterations of host-gut microbiome interactions in multiple sclerosis. EBioMedicine. 2022 Feb;76:103798.

Tags
Multiple sclerosis Neurodegenerative disease Meat Immune system

en_view en_sources

    See also

    The gut microbiome and chronic inflammatory diseases
    Photo : The gut microbiome and neurodegeneration The gut microbiome and neurodegeneration
    Created 15 April 2022
    Updated 21 April 2022

    About this article

    To know more about this topic.

    Main topic

    Neurodegenerative disease

    Medical practice

    Gastroenterology

    Content type

    News
    Gastroenterology

    The blue poop challenge: a reliable method to evaluate gut transit?

    By Pr. Gianluca Ianiro Gastroenterology Department, Fondazione Policlinico Universitario Agostino Gemelli- ...

    Find out more

    New perspectives in autism: the role of microbiota in social communication

    Overview By Dr. Vincent Trebossen Child and Adolescent P...

    Find out more

    Gut microbiota #15

    By Pr. Markku Voutilainen Turku University Faculty of Medicine; Turku University Hospital, Department of Ga...

    Find out more

    Microbiome topics at gastro 2021

    Congress Review By Pr. Eamonn M M Quigley Lynda K and David M Underwood Center for Digestive Disorders, Di...

    Find out more

    Commensal clostridiales strains mediate effective anti-cancer immune response against solid tumours

    Commented articles - Adults' section By Pr. Harry Sokol ...

    Find out more

    Microbiota in covid-19 pandemic

    Overview By Pr. Conceição Calhau NOVA Medical School, New University of Lisbon, Portugal By Pr. Pedro Povo...

    Find out more

    Association between fungal dysbiosis and environment

    The fungal portion of the gut microbiota (or mycobiota) has been much less studied than the bacterial porti...

    Find out more

    From diarrhea to chronic diseases: the well-documented consequences of antibiotic-related gut microbiota dysbiosis

    Antibiotic treatment may sometimes take place without any...

    Find out more

    Continue reading

    News
    Photo: Neonatal sepsis: the microbiota pays a heavy price for antibiotic use
    09.05.2022

    Neonatal sepsis: the microbiota pays a heavy price for antibiotic use

    Read the article
    26.04.2022

    Severe obesity: the vicious circle of biotin metabolism

    Read the article
    22.04.2022

    SCFAs: new intestinal markers of Parkinson’s disease?

    Read the article
    08.04.2022

    Inflammatory Bowel Disease (IBD): do microplastics condition severity?

    Read the article
    04.04.2022

    The microbiota, a significant factor in smoking cessation

    Read the article
    30.04.2019

    The lingual microbiota, biomarker of pancreatic cancer?

    Read the article
    15.06.2021

    Autism: link between severity of the disorder and changes in the gut microbiota?

    Read the article
    Actu PRO : A chaque tumeur son microbiote
    20.11.2020

    Each tumor has its own microbiota

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    NL13_cover
    Check out latest newsletter
    IBS, Microbiota & Covid-19
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

    Lay public section

    Find here your dedicated section

    en_redirection

    en_you_are_about_to_leave

    • en_be_redirected
    • en_stay_on_biocodex

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive once a month the “Microbiota Digest” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    Photo: Neonatal sepsis: the microbiota pays a heavy price for antibiotic use
    09.05.2022

    Neonatal sepsis: the microbiota pays a heavy price for antibiotic use

    Read the article
    04.05.2022

    Miscarriage: Is vaginal dysbiosis a suspect?

    Read the article
    26.04.2022

    Severe obesity: the vicious circle of biotin metabolism

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive once a month the “Microbiota Digest” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo